Proteome Sciences plc (LON:PRM – Get Free Report) was down 16.7% during mid-day trading on Thursday . The company traded as low as GBX 2.30 ($0.03) and last traded at GBX 2.30 ($0.03). Approximately 288,265 shares changed hands during mid-day trading, an increase of 81% from the average daily volume of 159,581 shares. The stock had previously closed at GBX 2.76 ($0.04).
Proteome Sciences Stock Performance
The business’s fifty day moving average is GBX 2.98 and its 200-day moving average is GBX 3.37. The firm has a market cap of £8.00 million, a P/E ratio of -271.00 and a beta of 0.07.
About Proteome Sciences
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Read More
- Five stocks we like better than Proteome Sciences
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Battle of the Retailers: Who Comes Out on Top?
- What Are Dividend Champions? How to Invest in the Champions
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- How to Invest in the FAANG Stocks
- MarketBeat Week in Review – 10/28 – 11/1
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
